Synthesis of 13C-labeled chenodeoxycholic, hyodeoxycholic, and ursodeoxycholic acids for the study of bile acid metabolism in liver disease
✍ Scribed by S. Matern; H.-U. Marschall; A. Schill; B. Schumacher; W. Lehnert; J. Sjövall; H. Matern
- Book ID
- 115827164
- Publisher
- Elsevier Science
- Year
- 1991
- Tongue
- English
- Weight
- 856 KB
- Volume
- 203
- Category
- Article
- ISSN
- 0009-8981
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The efficacy of 2 years of treatment with ursodeoxycholic acid (UDCA) in cystic fibrosis (CF)-associated liver disease was evaluated by liver biopsies and liver function tests in 10 patients aged 8 to 28 years. The metabolism of UDCA was investigated by analysis of urinary bile acids with fast atom
Beneficial effects of ursodeoxycholic acid in chronic cholestatic liver diseases have been attributed to displacement of hydrophobic bile acids from the endogenous bile acid pool. To test this hypothesis, we determined pool sizes, fractional turnover rates, synthesis/input rates and serum levels of
## Abstract A synthetic route to isotopically labelled forms of the tropane alkaloid hyoscyamine, including (__RS__)‐[3′, 3′,‐^2^H~2~]‐ (**2a**) and (__RS__)‐[1′‐^13^C, 3′, 3′,‐^2^H~2~]‐ (**2b**) hyoscyamines, involving the reaction between phenylacetyl tropine and formaldehyde is described. The is